FEEDS
Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
Osaka, Japan, And São Jerônimo, Brazil (ots/PRNewswire) - ? Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") and Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. (Rio Grande do Sul, Brazil, "Multilab") today jointly ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda Announces Acceptance of European Marketing Authorisation Application for Peginesatide, an Investigational Compound for the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis
London And Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that Takeda Global Research & Development Centre (Europe) Ltd received confirmation of acceptance for assessment from the European Medicines ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited announced today strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy Nycomed operations, strengthen its presence ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Europäische Kommission schließt sich der Überzeugung der Europäischen Arzneimittelagentur an, dass Pioglitazon enthaltende Arzneimittel auch weiterhin eine zulässige Behandlungsoption für bestimmte Typ-2-Diabetespatienten bleibt
Osaka, Japan, und London (ots/PRNewswire) - Die Neubewertung der Europäischen Kommission ist mit der Akzeptierung des CHMP-Standpunktes vom Oktober 2011 nun abgeschlossen Takeda Pharmaceutical Company Limited ("Takeda") gab heute bekannt, dass sich ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda's Edarbi® (azilsartan medoxomil) Receives European Marketing Authorisation for the Treatment of Essential Hypertension
London and Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Takeda) today announced that the European Commission has granted marketing authorisation for Edarbi(R) (azilsartan medoxomil), a new once-daily angiotensin receptor ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
EMA-Neubewertung präzisiert und bestätigt früheren CHMP-Standpunkt eines positiven Nutzen-Risiko-Verhältnisses für Pioglitazon enthaltende Präparate
Osaka, Japan, und London (ots/PRNewswire) - Europäische Arzneimittelagentur bestätigt, dass Pioglitazon enthaltende Arzneimittel von Takeda weiterhin eine relevante Behandlungsoption für geeignete Typ-2-Diabetespatienten bleiben Takeda ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda Completes Acquisition and Names New CEO of Nycomed
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited announced it has completed its acquisition of Nycomed A/S ("Nycomed") for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda gibt EMA-Annahme des Zulassungsantrags für die Vermarktung von ADCETRIS(TM) (Brentuximab Vedotin) bekannt
Osaka, Japan und Cambridge, Massachusetts (ots/PRNewswire) -- Takeda Pharmaceutical Company Limited gab heute gemeinsam mit seiner hundertprozentigen Tochtergesellschaft Millennium: The Takeda Oncology Company bekannt, dass die Europäische ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda ernennt neuen CEO für das europäische Geschäft
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited ("Takeda") kündigte an, dass Trevor Smith, gegenwärtig Vice President, International Strategy, mit Wirkung vom 1. April die Rolle des Chief Executive Officer von Takeda ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
First Treatment to Improve Survival in 20 Years Now Available for Patients With Osteosarcoma (Bone Cancer)
Osaka, Japan and London (ots/PRNewswire) - Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Pharmaceuticals Europe Limited ("TPEU"), its wholly owned subsidiary for oversight of pan-European sales and marketing, jointly announced today ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
Takeda to Establish Four Sales and Marketing Subsidiaries to Expand its Operations in Mexico, Turkey and Five Other Countries in Europe
Osaka, Japan (ots/PRNewswire) - Takeda Pharmaceutical Company Limited (Osaka, Japan, "Takeda") announced today it will establish four new commercial subsidiaries covering Mexico, Turkey, Sweden, Norway, Denmark, Belgium and Luxembourg. The new ... weiter zur Pressemitteilung von Takeda Pharmaceutical Company Limited
